P, K., W, F., R, G., LK, D., CP, W., J, S., . . . M, H. (2023). Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. Annals of hematology, 102(2), 323. https://doi.org/10.1007/s00277-022-05075-4
Chicago Style (17th ed.) CitationP, Klement, et al. "Molecular Response Patterns in Relapsed/refractory AML Patients Treated with Selinexor and Chemotherapy." Annals of Hematology 102, no. 2 (2023): 323. https://doi.org/10.1007/s00277-022-05075-4.
MLA (9th ed.) CitationP, Klement, et al. "Molecular Response Patterns in Relapsed/refractory AML Patients Treated with Selinexor and Chemotherapy." Annals of Hematology, vol. 102, no. 2, 2023, p. 323, https://doi.org/10.1007/s00277-022-05075-4.
Warning: These citations may not always be 100% accurate.